Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes
Carregando...
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2019
Editora
ELSEVIER SCIENCE BV
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
GARCIA-ROSA, Sheila
SACHETTO, Ana Teresa Azevedo
MORETTI, Ana Iochabel Soares
SILVA, Nathalia Tenguan
MARTINS-DE-SOUZA, Daniel
SANTORO, Marcelo Larami
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REDOX BIOLOGY, v.22, article ID UNSP 101142, 14p, 2019
Resumo
Redox-related plasma proteins are candidate reporters of protein signatures associated with endothelial structure/function. Thiol-proteins from protein disulfide isomerase (PDI) family are unexplored in this context. Here, we investigate the occurrence and physiological significance of a circulating pool of PDI in healthy humans. We validated an assay for detecting PDI in plasma of healthy individuals. Our results indicate high inter-individual (median = 330 pg/mL) but low intra-individual variability over time and repeated measurements. Remarkably, plasma PDI levels could discriminate between distinct plasma proteome signatures, with PDI-rich ( > median) plasma differentially expressing proteins related to cell differentiation, protein processing, housekeeping functions and others, while PDI-poor plasma differentially displayed proteins associated with coagulation, inflammatory responses and immunoactivation. Platelet function was similar among individuals with PDI-rich vs. PDI-poor plasma. Remarkably, such protein signatures closely correlated with endothelial function and phenotype, since cultured endothelial cells incubated with PDI-poor or PDI-rich plasma recapitulated gene expression and secretome patterns in line with their corresponding plasma signatures. Furthermore, such signatures translated into functional responses, with PDI-poor plasma promoting impairment of endothelial adhesion to fibronectin and a disturbed pattern of wound-associated migration and recovery area. Patients with cardiovascular events had lower PDI levels vs. healthy individuals. This is the first study describing PDI levels as reporters of specific plasma proteome signatures directly promoting contrasting endothelial phenotypes and functional responses.
Palavras-chave
Protein disulfide isomerase, Plasma proteome, Endothelial cells, Plasma protein signatures, Thiol proteins
Referências
- Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010
- Araujo TLS, 2017, REDOX BIOL, V12, P1004, DOI 10.1016/j.redox.2017.04.034
- Araujo TLS, 2017, FREE RADICAL BIO MED, V103, P199, DOI 10.1016/j.freeradbiomed.2016.12.021
- Badrichani AZ, 1999, J CLIN INVEST, V103, P543, DOI 10.1172/JCI2517
- Banfi C, 2005, PROTEOMICS, V5, P4443, DOI 10.1002/pmic.200402017
- Bekendam RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12579
- Bekendam RH, 2016, BASIC CLIN PHARMACOL, V119, P42, DOI 10.1111/bcpt.12573
- Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151
- Cassoli JS, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700209
- CHEN K, 1995, BRIT J HAEMATOL, V90, P425, DOI 10.1111/j.1365-2141.1995.tb05169.x
- CHEN K, 1992, BLOOD, V79, P2226
- Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532
- Crescente M, 2016, ARTERIOSCL THROM VAS, V36, P1164, DOI 10.1161/ATVBAHA.116.307461
- Damgaard RB, 2011, DISCOV MED, V11, P221
- Druhan LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170261
- Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311
- Essex DW, 2018, CURR OPIN HEMATOL, V25, P395, DOI 10.1097/MOH.0000000000000449
- Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]
- Essex DW, 1999, BIOCHEMISTRY-US, V38, P10398, DOI 10.1021/bi990694s
- Fan GQ, 2016, ONCOTARGET, V7, P83231, DOI 10.18632/oncotarget.13081
- Fernandes DC, 2009, ARCH BIOCHEM BIOPHYS, V484, P197, DOI 10.1016/j.abb.2009.01.022
- Flaumenhaft R, 2017, CURR OPIN HEMATOL, V24, P439, DOI 10.1097/MOH.0000000000000362
- Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456
- FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665
- Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951
- Garcia S, 2017, ADV EXP MED BIOL, V974, P193, DOI 10.1007/978-3-319-52479-5_15
- Giannakopoulos B, 2012, J AUTOIMMUN, V39, P121, DOI 10.1016/j.jaut.2012.05.005
- Han JY, 2016, REDOX BIOL, V9, P306, DOI 10.1016/j.redox.2016.09.003
- Hayashida K., 2018, CIRCULATION, V139
- Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037
- Iqbal A, 2014, ARCH BIOCHEM BIOPHYS, V557, P72, DOI 10.1016/j.abb.2014.06.013
- Jannes CE, 2015, ATHEROSCLEROSIS, V238, P101, DOI 10.1016/j.atherosclerosis.2014.11.009
- Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228
- Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184
- Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x
- Joshi A, 2018, CIRCULATION, V138, P2482, DOI 10.1161/CIRCULATIONAHA.118.036823
- Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954
- Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037
- Lin L, 2015, J BIOL CHEM, V290, P23543, DOI 10.1074/jbc.M115.666180
- Montano SJ, 2014, ANAL BIOCHEM, V449, P139, DOI 10.1016/j.ab.2013.12.025
- Mor-Cohen R, 2016, ANTIOXID REDOX SIGN, V24, P16, DOI 10.1089/ars.2014.6149
- Moraes MS, 2014, ARCH BIOCHEM BIOPHYS, V558, P14, DOI 10.1016/j.abb.2014.06.011
- Moretti AIS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16947-5
- Oliveira PVS, 2018, CLIN SCI, V132, P1257, DOI 10.1042/CS20180157
- Peixoto AS, 2018, J BIOL CHEM, V293, P1450, DOI 10.1074/jbc.M117.807016
- Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
- Prado GN, 2013, FASEB J, V27, P4619, DOI 10.1096/fj.13-228577
- Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025
- Raturi A, 2008, BBA-BIOMEMBRANES, V1778, P2790, DOI 10.1016/j.bbamem.2008.07.003
- Sharda A, 2018, EXPERT REV HEMATOL, V11, P437, DOI 10.1080/17474086.2018.1452612
- Sharda A, 2015, BLOOD, V125, P1633, DOI 10.1182/blood-2014-08-597419
- Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007
- Stopa JD, 2018, THROMB RES, V164, pS130, DOI 10.1016/j.thromres.2018.01.005
- Stopa JD, 2017, J BIOL CHEM, V292, P9063, DOI 10.1074/jbc.M116.771832
- Stopa JD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89373
- Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4
- Tanaka LY, 2016, HYPERTENSION, V67, P613, DOI 10.1161/HYPERTENSIONAHA.115.06177
- Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704
- Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30
- Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x
- Vegvari Akos, 2011, J Clin Bioinforma, V1, P24, DOI 10.1186/2043-9113-1-24
- Voigtlaender M, 2016, HAEMOPHILIA, V22, pE537, DOI 10.1111/hae.13074
- Wang L, 2015, FREE RADICAL BIO MED, V83, P305, DOI 10.1016/j.freeradbiomed.2015.02.007
- Xu SL, 2014, DRUG DISCOV TODAY, V19, P222, DOI 10.1016/j.drudis.2013.10.017
- Xu SL, 2012, P NATL ACAD SCI USA, V109, P16348, DOI 10.1073/pnas.1205226109
- Zhou JS, 2015, J CLIN INVEST, V125, P4391, DOI 10.1172/JCI80319